Ballicules.com

Ketotifen

ZADITOR

Pronunciation: kee-toe-TYE-fen

Ketotifen ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Ketotifen ballicule

What it isH1 antagonist with mast-cell stabilization; allergic conjunctivitis.

Why this oneIts inexpensive over-the-counter eye drops combine immediate antihistamine relief with prevention of further mediator release.

What limits itLocal burning or irritation can stop use; oral ketotifen, used outside the US, is sedating.

Ketotifen molecular structure (skeletal formula)
Molecular structure: Ketotifen

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Eye itch due to allergyadults & children ≥3 yr1 drop in affected eye(s) BID (q8-12h)no more than twice per day

Renal Undefined

Hepatic Undefined

Instructions

Available strengths

Pregnancy Undefined

Lactation Undefined

Cost

Ketotifen (ZADITOR)
Strength#/mogeneric $/unitCostPlus
0.025 %dropsper unitnot offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Ketotifen is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.

Generic entry2012

NO BOXED WARNINGS

Principal riskLocal irritation

Classes and tags

Clinical profile

Therapeutic safety burden0 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryNot assigned — OTC/monograph

Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.

Open Ketotifen in the interactive console ↗